• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在消化系统癌症中鉴定出的富含AT序列相互作用结构域基因家族的表达特征

Expression Signature of the AT-Rich Interactive Domain Gene Family Identified in Digestive Cancer.

作者信息

Lu Yongqu, Liu Zhenzhen, Wang Wendong, Chen Xin, Zhou Xin, Fu Wei

机构信息

Department of General Surgery, Peking University Third Hospital, Beijing, China.

出版信息

Front Med (Lausanne). 2022 Jan 20;8:775357. doi: 10.3389/fmed.2021.775357. eCollection 2021.

DOI:10.3389/fmed.2021.775357
PMID:35127746
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8811461/
Abstract

BACKGROUND

The AT-rich interactive domain (ARID) gene family of 15 proteins has an important role in development and proliferation. Gene expression alterations of the ARID family are correlated with the pathogenesis of digestive cancer, but systematic research has not been conducted.

METHODS

We obtained transcriptome sequencing data, clinical characteristics and stemness indices of the seven main types of digestive cancer (cholangiocarcinoma, colon adenocarcinoma, oesophageal carcinoma, liver hepatocellular carcinoma, pancreatic adenocarcinoma, rectum adenocarcinoma and stomach adenocarcinoma) from public pan-cancer data to combine the analysis of the expression and prognostic signature of the ARID gene family. The stromal and immune scores for each sample were calculated to explore the correlations between the ARID gene family members and the tumour microenvironment.

RESULTS

After screening, 1,920 digestive cancer samples were included in our study. was expressed at low levels throughout the digestive cancer samples. The expression levels of and were relatively high, but there was striking heterogeneity across the different cancer types for specific family members. The survival analysis indicated that many genes were significantly related to the prognosis of patients with liver hepatocellular carcinoma. The stemness indices, stromal score, and immune score analysis showed that the expression of a single ARID gene had characteristic consistency in each tumour, but the levels among the different genes still varied.

CONCLUSION

Our systematic study of the ARID gene family and its association with the immune infiltrate, tumour microenvironment and outcomes of digestive cancer patients focus on the complex relations and indicate the need to study each ARID member as an individual in a specific cancer type.

摘要

背景

由15种蛋白质组成的富含AT的相互作用结构域(ARID)基因家族在发育和增殖中起重要作用。ARID家族的基因表达改变与消化系统癌症的发病机制相关,但尚未进行系统研究。

方法

我们从公共泛癌数据中获取了七种主要消化系统癌症(胆管癌、结肠腺癌、食管癌、肝细胞肝癌、胰腺腺癌、直肠腺癌和胃腺癌)的转录组测序数据、临床特征和干性指数,以联合分析ARID基因家族的表达和预后特征。计算每个样本的基质和免疫评分,以探索ARID基因家族成员与肿瘤微环境之间的相关性。

结果

筛选后,1920例消化系统癌症样本纳入我们的研究。 在整个消化系统癌症样本中表达水平较低。 和 的表达水平相对较高,但特定家族成员在不同癌症类型之间存在显著异质性。生存分析表明,许多基因与肝细胞肝癌患者的预后显著相关。干性指数、基质评分和免疫评分分析表明,单个ARID基因的表达在每种肿瘤中具有特征一致性,但不同基因之间的水平仍有所不同。

结论

我们对ARID基因家族及其与免疫浸润、肿瘤微环境和消化系统癌症患者预后的关联进行的系统研究聚焦于复杂关系,并表明需要在特定癌症类型中将每个ARID成员作为个体进行研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/12cc9ebb9a4c/fmed-08-775357-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/1b4dfdc49050/fmed-08-775357-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/f967e96c953f/fmed-08-775357-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/5109994c3ba4/fmed-08-775357-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/77777133c160/fmed-08-775357-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/12cc9ebb9a4c/fmed-08-775357-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/1b4dfdc49050/fmed-08-775357-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/f967e96c953f/fmed-08-775357-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/5109994c3ba4/fmed-08-775357-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/77777133c160/fmed-08-775357-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8779/8811461/12cc9ebb9a4c/fmed-08-775357-g0005.jpg

相似文献

1
Expression Signature of the AT-Rich Interactive Domain Gene Family Identified in Digestive Cancer.在消化系统癌症中鉴定出的富含AT序列相互作用结构域基因家族的表达特征
Front Med (Lausanne). 2022 Jan 20;8:775357. doi: 10.3389/fmed.2021.775357. eCollection 2021.
2
Pan-cancer analysis of ARID family members as novel biomarkers for immune checkpoint inhibitor therapy.泛癌症分析 ARID 家族成员作为免疫检查点抑制剂治疗的新型生物标志物。
Cancer Biol Ther. 2022 Dec 31;23(1):104-111. doi: 10.1080/15384047.2021.2011643.
3
Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma.ARID 家族成员的全面分析及其与肝细胞癌预后和肿瘤微环境的关系。
J Immunol Res. 2022 Mar 30;2022:1688460. doi: 10.1155/2022/1688460. eCollection 2022.
4
The panoramic picture of pepsinogen gene family with pan-cancer.胃蛋白酶原基因家族的全景图与泛癌。
Cancer Med. 2020 Dec;9(23):9064-9080. doi: 10.1002/cam4.3489. Epub 2020 Oct 17.
5
The molecular feature of macrophages in tumor immune microenvironment of glioma patients.胶质瘤患者肿瘤免疫微环境中巨噬细胞的分子特征。
Comput Struct Biotechnol J. 2021 Aug 14;19:4603-4618. doi: 10.1016/j.csbj.2021.08.019. eCollection 2021.
6
Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.基于肝癌干细胞特征的预后标志物的免疫价值
Front Cell Dev Biol. 2021 Aug 2;9:710207. doi: 10.3389/fcell.2021.710207. eCollection 2021.
7
Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.基于癌症干性的肺腺癌和肺鳞癌预后免疫相关基因特征。
Front Endocrinol (Lausanne). 2021 Oct 21;12:755805. doi: 10.3389/fendo.2021.755805. eCollection 2021.
8
Expression and prognostic values of ARID family members in breast cancer.ARID 家族成员在乳腺癌中的表达及预后价值。
Aging (Albany NY). 2021 Feb 11;13(4):5621-5637. doi: 10.18632/aging.202489.
9
Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma.泛癌症分析免疫细胞浸润鉴定出肺腺癌预后免疫细胞特征评分(ICCS)。
Front Immunol. 2020 Jun 30;11:1218. doi: 10.3389/fimmu.2020.01218. eCollection 2020.
10
A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer.基于肿瘤微环境中基质/免疫评分的五基因签名及其对肝癌的临床意义。
DNA Cell Biol. 2020 Sep;39(9):1621-1638. doi: 10.1089/dna.2020.5512. Epub 2020 Aug 4.

引用本文的文献

1
Machine learning and multi-omics data reveal driver gene-based molecular subtypes in hepatocellular carcinoma for precision treatment.机器学习和多组学数据揭示了基于驱动基因的肝细胞癌分子亚型,以实现精准治疗。
PLoS Comput Biol. 2024 May 10;20(5):e1012113. doi: 10.1371/journal.pcbi.1012113. eCollection 2024 May.
2
The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma.富含AT序列相互作用结构域(ARID)家族成员在肝细胞癌患者中的预后价值
Evid Based Complement Alternat Med. 2022 Aug 18;2022:1150390. doi: 10.1155/2022/1150390. eCollection 2022.
3
Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma.

本文引用的文献

1
Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients.中国肝门部胆管癌患者基因组改变的综合分析。
Int J Clin Oncol. 2021 Apr;26(4):717-727. doi: 10.1007/s10147-020-01846-z. Epub 2021 Jan 2.
2
Neurotensin pathway in digestive cancers and clinical applications: an overview.神经降压素通路在消化道癌症中的作用及其临床应用:综述。
Cell Death Dis. 2020 Dec 2;11(12):1027. doi: 10.1038/s41419-020-03245-8.
3
Exome sequencing identifies ARID2 as a novel tumor suppressor in early-onset sporadic rectal cancer.
ARID 家族成员的全面分析及其与肝细胞癌预后和肿瘤微环境的关系。
J Immunol Res. 2022 Mar 30;2022:1688460. doi: 10.1155/2022/1688460. eCollection 2022.
外显子组测序鉴定 ARID2 为散发早发性直肠癌的新型抑癌基因。
Oncogene. 2021 Jan;40(4):863-874. doi: 10.1038/s41388-020-01537-z. Epub 2020 Dec 1.
4
ARID3A promotes the development of colorectal cancer by upregulating AURKA.ARID3A 通过上调 AURKA 促进结直肠癌的发展。
Carcinogenesis. 2021 Apr 30;42(4):578-586. doi: 10.1093/carcin/bgaa118.
5
ARID2 Chromatin Remodeler in Hepatocellular Carcinoma.ARID2 染色质重塑因子在肝细胞癌中的作用。
Cells. 2020 Sep 23;9(10):2152. doi: 10.3390/cells9102152.
6
Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment.外泌体来源的 miR-142-5p 重塑淋巴管并诱导 IDO 促进肿瘤微环境中的免疫豁免。
Cell Death Differ. 2021 Feb;28(2):715-729. doi: 10.1038/s41418-020-00618-6. Epub 2020 Sep 14.
7
Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming.子宫内膜中 ARID1A 的失活通过转录重编程与子宫内膜样肿瘤发生相关。
Nat Commun. 2020 Jun 1;11(1):2717. doi: 10.1038/s41467-020-16416-0.
8
Visualizing and interpreting cancer genomics data via the Xena platform.通过Xena平台可视化和解读癌症基因组学数据。
Nat Biotechnol. 2020 Jun;38(6):675-678. doi: 10.1038/s41587-020-0546-8.
9
ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors.ESTIMATE算法不适用于推断造血肿瘤或基质肿瘤中的肿瘤纯度以及基质和免疫细胞混合物。
Cancer Immunol Immunother. 2020 Jun;69(6):1153-1154. doi: 10.1007/s00262-020-02526-7. Epub 2020 Mar 9.
10
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.染色质重塑因子 ARID2 通过 DNMT1-Snail 轴抑制肝细胞癌转移。
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4770-4780. doi: 10.1073/pnas.1914937117. Epub 2020 Feb 18.